- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT05278702
Autonomic Nervous System Dysfunction in Patients With End-stage Kidney Disease
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
This is an observational study performed in the Department of Nephrology, Hippokration Hospital, Thessaloniki, Greece. For the purposes of this study, adult patients (>18 years) with ESKD being treated with hemodialysis (HD) (on standard thrice-weekly HD treatment) or peritoneal dialysis (PD) for at least 3 months, fulfilling the inclusion/exclusion criteria were invited to participate. PD and HD patients will be matched by a blinded member of our team based on age, gender and dialysis vintage (i.e. the duration of time after the point they started renal replacement therapy for ESRD) in a 1:1 ratio. All included patients signed a written informed consent form. The study protocol was approved by the Ethics Committee of the School of Medicine, Aristotle University of Thessaloniki. All procedures and evaluations are performed according to the Declaration of Helsinki 2013 Amendment.
Evaluation of participants includes the recording of demographics and anthropometric characteristics, medical history, concomitant medications and dialysis-related parameters, as well as physical examination and venous blood sampling for routine laboratory tests. Participants are instructed to visit the Department one hour before the programmed follow-up visit at their unit (PD patients); HD patients are instructed to visit the Department on 2 consecutive days (mid-week dialysis day and the corresponding dialysis-off day). All procedures are performed in a room with an ambient temperature of 23-24oC. Firstly, participants are oriented and familiarized with the experimental procedures and are prepared for the hemodynamic and cardiovascular examinations. Continuous beat-by-beat BP and heart rate are monitored using finger photoplethysmography (Finometer PRO, Finapres Medical Systems, Amsterdam, the Netherlands) throughout the protocol. An inflatable cuff is placed on the middle finger of the non-access hand maintained at heart level. After a 5-min rest, all participants underwent a mental task (countdown from 100 to 0 by 7, performed twice), an orthostatic test (5 min with the patient at the supine position followed by 5 min with the patient in upright position), and a mild physical task [3-minute submaximal handgrip exercise test (set of 30 s exercise at 35% MVC with 3 s rest] (K-Force, K-invent). At the completion of the exercise protocol, the Rate of Perceived Exertion (RPE) is assessed using the Borg scale.
For data analysis, beat-by-beat SBP and DBP will be averaged per testing session and exported using the Beatscope software (version 1.a, Finapres Medical Systems, Amsterdam, the Netherlands). From pulse pressure profiles, beat-by-beat heart rate (HR) and stroke volume (SV, ml) will be computed, using the Modelflow method; cardiac output (L/min) and systemic vascular resistance (SVR, mmHg.s/mL), will also be computed using Beatscope. HRV analysis will be performed with the HRV Analysis software Kubios (version 3.3.1, Kubios Oy, 2019) by the same researcher to eliminate inter-observer variability. R-R interval series will be checked for ectopic beats or artifacts. The root mean square of successive differences (RMSSD) between the coupling intervals of adjacent R-R intervals will be used as a parasympathetic activity index. Baroreceptor sensitivity (ms/mmHg) will be assessed by examining the spontaneous fluctuations in the blood pressure as assessed by the cross-correlation method using the Beatscope 1a software).
Studietype
Inschrijving (Verwacht)
Contacten en locaties
Studiecontact
- Naam: Danai Faitatzidou
- Telefoonnummer: +302313312930
- E-mail: d.a.n.a.i.90@hotmail.com
Studie Contact Back-up
- Naam: Pantelis Sarafidis
- Telefoonnummer: +302313312930
- E-mail: psarafidis11@yahoo.gr
Studie Locaties
-
-
-
Thessaloniki, Griekenland, 54642
- Werving
- Department of Nephrology, Hippokration Hospital
-
Contact:
- Danai Faitatzidou
- Telefoonnummer: +302313312930
- E-mail: d.a.n.a.i.90@hotmail.com
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Age >18 years
- ESKD individuals treated with either hemodialysis (standard thrice weekly schedule) or peritoneal dialysis for at least 3 months
- Provision of informed written consent
Exclusion Criteria:
- Antihypertensive treatment modifcation during one month prior to study enrollment
- Modification of treatment for neurological disorders one month prior to study enrollment
- Active malignant disease or other comorbidity with poor prognosis
- History of neurological disorders (e.g. Parkinson's disease, multiple sclerosis, etc) that cause primary ANS dysfunction
- History of ANS dysfunction secondary to diabetes mellitus, amyloidosis, autoimmune disorders, etc.
- Active infection or relevant inter-current illness.
- History of drug or alcohol abuse or severe mental disorder
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
---|
hemodialysis
|
peritoneal dialysis
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
The difference in the root mean square of successive R-R differences [RMSSD (ms)] parameter of heart rate variability during the mental arithmetic test between the examination during the dialysis session and the examination in the out-of-dialysis day
Tijdsspanne: Baseline
|
The root mean square of successive differences (RMSSD) between the coupling intervals of adjacent R-R intervals will be used as a parasympathetic activity index.
RMSSD will be calculated with the HRV Analysis software Kubios (version 3.3.1,
Kubios Oy, 2019)
|
Baseline
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
The difference in baroreceptor-sensitivity (ms/mmHg) during mental-arithmetic-test between examination during the session and examination in the out-of-dialysis day.
Tijdsspanne: Baseline
|
Baroreceptor sensitivity (ms/mmHg) will be assessed by examining the spontaneous fluctuations in the blood pressure as assessed by the cross-correlation method using the Beatscope 1a software).
|
Baseline
|
The difference in stroke-volume (ml) during mental-arithmetic-test between examination during the session and examination in the out-of-dialysis day.
Tijdsspanne: Baseline
|
Beat-by-beat stroke volume (ml) will be averaged per testing session and exported using the Beatscope software (version 1.a, Finapres Medical Systems, Amsterdam, the Netherlands)
|
Baseline
|
The difference in cardiac-output (L/min) during mental-arithmetic-test between examination during the session and examination in the out-of-dialysis day
Tijdsspanne: Baseline
|
Beat-by-beat cardiac output (L/min) will be averaged per testing session and exported using the Beatscope software (version 1.a, Finapres Medical Systems, Amsterdam, the Netherlands).
|
Baseline
|
The difference in total-peripheral-resistance during mental-arithmetic-test between examination during the session and examination in the out-of-dialysis day.
Tijdsspanne: Baseline
|
Beat-by-beat total peripheral resistance (mmHg.s/mL)
will be averaged per testing session and exported using the Beatscope software (version 1.a, Finapres Medical Systems, Amsterdam, the Netherlands)
|
Baseline
|
The difference in both SBP and DBP (mmHg) during mental-arithmetic-test between examination during the session and examination in the out-of-dialysis day.
Tijdsspanne: Baseline
|
Beat-by-beat SBP and DBP will be averaged per testing session and exported using the Beatscope software (version 1.a, Finapres Medical Systems, Amsterdam, the Netherlands)
|
Baseline
|
The difference in in the root mean square of successive R-R differences [RMSSD (ms)] parameter of heart rate variability during the handgrip test between dialysis session start and session end.
Tijdsspanne: Baseline
|
The root mean square of successive differences (RMSSD) between the coupling intervals of adjacent R-R intervals will be used as a parasympathetic activity index.
RMSSD will be calculated with the HRV Analysis software Kubios (version 3.3.1,
Kubios Oy, 2019)
|
Baseline
|
The difference in baroreceptor sensitivity (ms/mmHg) during the handgrip test between dialysis session start and session end.
Tijdsspanne: Baseline
|
Baroreceptor sensitivity (ms/mmHg) will be assessed by examining the spontaneous fluctuations in the blood pressure as assessed by the cross-correlation method using the Beatscope 1a software).
|
Baseline
|
The difference in cardiac output (L/min) during the handgrip test between dialysis session start and session end.
Tijdsspanne: Baseline
|
Beat-by-beat cardiac output (L/min) will be averaged per testing session and exported using the Beatscope software (version 1.a, Finapres Medical Systems, Amsterdam, the Netherlands)
|
Baseline
|
The difference in total peripheral resistance during the handgrip test between dialysis session start and session end.
Tijdsspanne: Baseline
|
Beat-by-beat total peripheral resistance (mmHg.s/mL)
will be averaged per testing session and exported using the Beatscope software (version 1.a, Finapres Medical Systems, Amsterdam, the Netherlands)
|
Baseline
|
The difference in both SBP and DBP (mmHg) during the handgrip test between dialysis session start and session end.
Tijdsspanne: Baseline
|
Beat-by-beat SBP and DBP will be averaged per testing session and exported using the Beatscope software (version 1.a, Finapres Medical Systems, Amsterdam, the Netherlands)
|
Baseline
|
The difference in stroke volume (ml) during the handgrip test between dialysis session start and session end.
Tijdsspanne: Baseline
|
Beat-by-beat stroke volume (ml) will be averaged per testing session and exported using the Beatscope software (version 1.a, Finapres Medical Systems, Amsterdam, the Netherlands)
|
Baseline
|
The difference in in the root mean square of successive R-R differences [RMSSD (ms)] parameter of heart rate variability during the orthostatic test between dialysis session start and session end
Tijdsspanne: Baseline
|
The root mean square of successive differences (RMSSD) between the coupling intervals of adjacent R-R intervals will be used as a parasympathetic activity index.
RMSSD will be calculated with the HRV Analysis software Kubios (version 3.3.1,
Kubios Oy, 2019)
|
Baseline
|
The difference in baroreceptor sensitivity (ms/mmHg) during the orthostatic test between dialysis session start and session end.
Tijdsspanne: Baseline
|
Baroreceptor sensitivity (ms/mmHg) will be assessed by examining the spontaneous fluctuations in the blood pressure as assessed by the cross-correlation method using the Beatscope 1a software).
|
Baseline
|
The difference in stroke volume (ml) during the orthostatic test between dialysis session start and session end.
Tijdsspanne: Baseline
|
Beat-by-beat stroke volume (ml) will be averaged per testing session and exported using the Beatscope software (version 1.a, Finapres Medical Systems, Amsterdam, the Netherlands)
|
Baseline
|
The difference in cardiac output (L/min) during the orthostatic test between dialysis session start and session end.
Tijdsspanne: Baseline
|
Beat-by-beat cardiac output (L/min) will be averaged per testing session and exported using the Beatscope software (version 1.a, Finapres Medical Systems, Amsterdam, the Netherlands)
|
Baseline
|
The difference in the total peripheral resistance during the orthostatic test between dialysis session start and session end.
Tijdsspanne: Baseline
|
Beat-by-beat total peripheral resistance (mmHg.s/mL)
will be averaged per testing session and exported using the Beatscope software (version 1.a, Finapres Medical Systems, Amsterdam, the Netherlands)
|
Baseline
|
The difference in both SBP and DBP (mmHg) during the orthostatic test between dialysis session start and session end.
Tijdsspanne: Baseline
|
Beat-by-beat SBP and DBP will be averaged per testing session and exported using the Beatscope software (version 1.a, Finapres Medical Systems, Amsterdam, the Netherlands)
|
Baseline
|
The difference in in the root mean square of successive R-R differences [RMSSD (ms)] parameter of heart rate variability during the handgrip test between hemodialysis and peritoneal dialysis patients:.
Tijdsspanne: Baseline
|
The root mean square of successive differences (RMSSD) between the coupling intervals of adjacent R-R intervals will be used as a parasympathetic activity index.
RMSSD will be calculated with the HRV Analysis software Kubios (version 3.3.1,
Kubios Oy, 2019)
|
Baseline
|
The difference in the baroreceptor sensitivity (ms/mmHg) during the handgrip test between hemodialysis and peritoneal dialysis patients:.
Tijdsspanne: Baseline
|
Baroreceptor sensitivity (ms/mmHg) will be assessed by examining the spontaneous fluctuations in the blood pressure as assessed by the cross-correlation method using the Beatscope 1a software).
|
Baseline
|
The difference in the stroke volume (ml) during the handgrip test between hemodialysis and peritoneal dialysis patients:.
Tijdsspanne: Baseline
|
Beat-by-beat stroke volume (ml) will be averaged per testing session and exported using the Beatscope software (version 1.a, Finapres Medical Systems, Amsterdam, the Netherlands)
|
Baseline
|
The difference in the total peripheral resistance during the handgrip test between hemodialysis and peritoneal dialysis patients:.
Tijdsspanne: Baseline
|
Beat-by-beat total peripheral resistance (mmHg.s/mL)
will be averaged per testing session and exported using the Beatscope software (version 1.a, Finapres Medical Systems, Amsterdam, the Netherlands)
|
Baseline
|
The difference in the cardiac output (L/min) during the handgrip test between hemodialysis and peritoneal dialysis patients.
Tijdsspanne: Baseline
|
Beat-by-beat cardiac output (L/min) will be averaged per testing session and exported using the Beatscope software (version 1.a, Finapres Medical Systems, Amsterdam, the Netherlands)
|
Baseline
|
The difference in both SBP and DBP (mmHg) during the handgrip test between hemodialysis and peritoneal dialysis patients.
Tijdsspanne: Baseline
|
Beat-by-beat SBP and DBP will be averaged per testing session and exported using the Beatscope software (version 1.a, Finapres Medical Systems, Amsterdam, the Netherlands)
|
Baseline
|
The difference in in the root mean square of successive R-R differences [RMSSD (ms)] parameter of heart rate variability during the orthostatic test between hemodialysis and peritoneal dialysis patients.
Tijdsspanne: Baseline
|
The root mean square of successive differences (RMSSD) between the coupling intervals of adjacent R-R intervals will be used as a parasympathetic activity index.
RMSSD will be calculated with the HRV Analysis software Kubios (version 3.3.1,
Kubios Oy, 2019)
|
Baseline
|
The difference in baroreceptor sensitivity (ms/mmHg) during the orthostatic test between hemodialysis and peritoneal dialysis patients.
Tijdsspanne: Baseline
|
Baroreceptor sensitivity (ms/mmHg) will be assessed by examining the spontaneous fluctuations in the blood pressure as assessed by the cross-correlation method using the Beatscope 1a software).
|
Baseline
|
The difference in cardiac output (L/min) during the orthostatic test between hemodialysis and peritoneal dialysis patients.
Tijdsspanne: Baseline
|
Beat-by-beat cardiac output (L/min) will be averaged per testing session and exported using the Beatscope software (version 1.a, Finapres Medical Systems, Amsterdam, the Netherlands)
|
Baseline
|
The difference in total peripheral resistance during the orthostatic test between hemodialysis and peritoneal dialysis patients.
Tijdsspanne: Baseline
|
Beat-by-beat total peripheral resistance (mmHg.s/mL)
will be averaged per testing session and exported using the Beatscope software (version 1.a, Finapres Medical Systems, Amsterdam, the Netherlands)
|
Baseline
|
The difference in stroke volume (ml) during the orthostatic test between hemodialysis and peritoneal dialysis patients.
Tijdsspanne: Baseline
|
Beat-by-beat stroke volume (ml) will be averaged per testing session and exported using the Beatscope software (version 1.a, Finapres Medical Systems, Amsterdam, the Netherlands)
|
Baseline
|
The difference in both SBP and DBP (mmHg) during the orthostatic test between hemodialysis and peritoneal dialysis patients.
Tijdsspanne: Baseline
|
Beat-by-beat SBP and DBP will be averaged per testing session and exported using the Beatscope software (version 1.a, Finapres Medical Systems, Amsterdam, the Netherlands)
|
Baseline
|
Medewerkers en onderzoekers
Publicaties en nuttige links
Algemene publicaties
- Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996 Mar 1;93(5):1043-65. No abstract available.
- Savica V, Musolino R, Di Leo R, Santoro D, Vita G, Bellinghieri G. Autonomic dysfunction in uremia. Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S118-21. doi: 10.1053/ajkd.2001.27418.
- Kamal A. Effect of hemodialysis on autonomic dysfunction in patients with chronic renal failure - biomed 2009. Biomed Sci Instrum. 2009;45:280-5.
- Galiatsatos P, Parakh K, Monti J, Thavarajah S, Aneke-Ogbu H, Watson A, Kim D, Wang NY, Shafi T, Silber HA. A finger photoplethysmography waveform during the valsalva maneuver detects changes in left heart filling pressure after hemodialysis. BMC Nephrol. 2015 Aug 14;16:138. doi: 10.1186/s12882-015-0135-0.
- Parati G, Casadei R, Groppelli A, Di Rienzo M, Mancia G. Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension. 1989 Jun;13(6 Pt 1):647-55. doi: 10.1161/01.hyp.13.6.647.
- Dipla K, Kousoula D, Zafeiridis A, Karatrantou K, Nikolaidis MG, Kyparos A, Gerodimos V, Vrabas IS. Exaggerated haemodynamic and neural responses to involuntary contractions induced by whole-body vibration in normotensive obese versus lean women. Exp Physiol. 2016 Jun 1;101(6):717-30. doi: 10.1113/EP085556.
- Westerhof BE, Gisolf J, Stok WJ, Wesseling KH, Karemaker JM. Time-domain cross-correlation baroreflex sensitivity: performance on the EUROBAVAR data set. J Hypertens. 2004 Jul;22(7):1371-80. doi: 10.1097/01.hjh.0000125439.28861.ed.
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- ΔΔ4844
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Nierfalen, chronisch
-
Children's Oncology GroupNational Cancer Institute (NCI)Actief, niet wervendStadium I Nier Wilms-tumor | Stadium II Kidney Wilms-tumor | Stadium III Kidney Wilms-tumor | Stadium IV Kidney Wilms-tumor | Volwassen Nier Wilms-tumor | Beckwith-Wiedemann-syndroom | Kidney Wilms-tumor | Diffuse hyperplastische perilobar nefroblastomatose | Rhabdoïde tumor van de nier | Stadium V Kidney...Verenigde Staten, Canada, Australië, Nieuw-Zeeland, Puerto Rico, Israël
-
Children's Oncology GroupNational Cancer Institute (NCI)VoltooidTerugkerend nierneoplasma bij kinderen | Stadium I Nier Wilms-tumor | Stadium II Kidney Wilms-tumor | Stadium III Kidney Wilms-tumor | Stadium IV Kidney Wilms-tumorVerenigde Staten
-
Children's Oncology GroupNog niet aan het wervenStadium I Nier Wilms-tumor | Stadium II Kidney Wilms-tumor | Stadium III Kidney Wilms-tumor | Stadium IV Kidney Wilms-tumor
-
CAMC Health SystemOnbekendAKI (Acute Kidney Injury) als gevolg van traumaVerenigde Staten
-
Children's Oncology GroupNational Cancer Institute (NCI)WervingStadium II Kidney Wilms-tumor | Stadium III Kidney Wilms-tumor | Stadium IV Kidney Wilms-tumor | Terugkerende Nier Wilms-tumor | Anaplastische Nier Wilms-tumorVerenigde Staten, Canada, Puerto Rico, Australië, Nieuw-Zeeland, Saoedi-Arabië
-
Ain Shams UniversityVoltooidAKI (Acute Kidney Injury) als gevolg van traumaEgypte
-
Children's Oncology GroupNational Cancer Institute (NCI)Actief, niet wervendStadium III Kidney Wilms-tumor | Stadium IV Kidney Wilms-tumorVerenigde Staten, Canada, Australië, Nieuw-Zeeland, Puerto Rico, Israël, Zwitserland
-
Children's Oncology GroupNational Cancer Institute (NCI)Actief, niet wervendStadium I Nier Wilms-tumor | Stadium II Kidney Wilms-tumor | Stadium III Kidney Wilms-tumorVerenigde Staten, Canada, Australië, Nieuw-Zeeland, Puerto Rico, Israël, Zwitserland